IFAM
PBYI icon

Institutional & Family Asset Management’s Puma Biotechnology PBYI Stock Holding History

Institutional & Family Asset Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-9
Closed -$1K – 867
2018
Q2 		$1K Hold
9
– – ﹤0.01% 805
2018
Q1 		$1K Buy
+9
New +$674 ﹤0.01% 799

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Institutional & Family Asset Management's PBYI Position: Q3 2018 in Review

Institutional & Family Asset Management sold out of Puma Biotechnology (PBYI) in Q3 2018, closing a stake of 9 shares — an estimated $1K sold.

Institutional & Family Asset Management first reported a position in PBYI in Q1 2018 and held it in 2 quarters. The position peaked at $1K in Q2 2018. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2018.

  • Institutional & Family Asset Management reported no remaining Puma Biotechnology position as of Q3 2018 after selling out during the quarter.
  • Institutional & Family Asset Management sold 9 Puma Biotechnology shares in Q3 2018, an estimated $1K.
  • Institutional & Family Asset Management first reported a position in Puma Biotechnology in Q1 2018 and held it in 2 quarters.
  • Institutional & Family Asset Management's Puma Biotechnology position peaked at $1K in Q2 2018.
  • 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2018.

Based on Institutional & Family Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.